Weijun Fan

8PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDeep learningTime series and spatial modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 05, 2026
Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

|Feb 19, 2026
Co-Ablation System for Pain Management in Bone Metastases: Retrospective Exploratory Study.

Hang Yuan, Wei-Li Xia, Ho-Young Song

|Jan 13, 2026
Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.

Shuanggang Chen, Han Qi, Lujun Shen

|Apr 15, 2025
The Value of no Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma After TACE: A Real-World Study.

Lujun Shen, Yiquan Jiang, Yueqian Wu

|Apr 09, 2025
Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma.

Lujun Shen, Tao Zhang, Jian Xu

|Feb 10, 2025
Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study.

Shuanggang Chen, Han Qi, Hongtong Tan

Pageof 2

Frequent Collaborators

1 joint publications

Hang Yuan

1 joint publications

Wei-Li Xia

1 joint publications

Ho-Young Song

1 joint publications

Lin Zheng